#bioportfolio نتائج البحث
Bioportfolio.com is now DrugGenius.com! Follow the DG twitter account at bit.ly/2JIu40p #druggenius #bioportfolio
druggenius.com
Drug Genius | Prescription Medication Identification & Information
Detailed prescription drug and medication information reviewed by pharmaceutical professionals. Comprehensive articles that are written in a clear and concise manner. Specializing in Interactions,...
Alnylam prepares to land first ##RNAi drug approval bit.ly/2CObXQO #bioportfolio
Our podcasts uncover the truth behind vaccine development and highlight the trends in drug delivery devices that will definitely be of use to @BioPortfolio #BioPortfolio, #Vaccinations #HealthyRBKC, #YourVoiceIsAmplified
Micro#RNA degradation by a conserved target #RNA regulates animal behavior bit.ly/2otRAUz #bioportfolio
Highthroughput identification of #RNA nuclear enrichment sequences: In the postgenomic era thousands of putative noncoding regulatory regions have been identified such as enhancers promoters long noncoding #RNAs l#ncRNAs and a cadre of… bit.ly/2FGlyPS #bioportfolio
Alnylam Pharmaceuticals Inc ALNY Medical Equipment Deals and Alliances Profile Report Updated 13022018 Prices from USD $250: SummaryAlnylam Pharmaceuticals Inc Alnylam is a biopharmaceutical company which discovers develops and… bit.ly/2G7uc9t #bioportfolio
A kinomewide ##RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8inhibitor treatment bit.ly/2D9wuQ2 #bioportfolio
Dice#RNA to Present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium: Dice#RNA Pharmaceuticals Inc. NasdaqD#RNA a leading developer of investigational ribonucleic acid interference ##RNAi therapeutics today… bit.ly/2tuFzDt #bioportfolio
A single nucleotide incorporation step limits human telomerase repeat addition activity: Human telomerase synthesizes telomeric DNA repeats GGTTAGn onto chromosome ends using a short template from its integral telomerase #RNA hTR. However… bit.ly/2pfmS27 #bioportfolio
Celsion Corp CLSN Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 15022018 Prices from USD $250: SummaryCelsion Corp Celsion is an oncology company that focuses on developing a portfolio of new #cancer treatments… bit.ly/2F9sTXZ #bioportfolio
Dice#RNA to Present at the Cowen and Company 38th Annual Health Care Conference: Dice#RNA Pharmaceuticals Inc. NasdaqD#RNA a leading developer of investigational ribonucleic acid interference ##RNAi therapeutics today announced that Douglas… bit.ly/2Ffhw0U #bioportfolio
Alnylam Retains Global Rights to Lumasiran an Investigational ##RNAi Therapeutic for the Treatment of Primary Hyperoxaluria Type 1 PH1: Company Plans to Accelerate Development with Phase 3 Start in Late 2018 Lumasiran Granted Breakthrough… bit.ly/2FtLZZ2 #bioportfolio
Mi#RNA Therapeutics Inc MIRN Financial and Strategic SWOT Analysis Review Report Updated 09032018 Prices from USD $300: SummaryMi#RNA Therapeutics Inc Mi#RNA is a clinical stage biopharmaceutical company that develops and commercializes… bit.ly/2FKePAj #bioportfolio
Qiagen NV QIA Medical Equipment Deals and Alliances Profile Report Updated 13022018 Prices from USD $250: SummaryQiagen NV Qiagen is a provider of molecular testing solutions. Its solutions include sample and assay technologies… bit.ly/2HEaVtn #bioportfolio
Dice#RNA Reports Fourth Quarter and Year End 2017 Financial and Operating Results and Provides Corporate Update: Management to Host Conference Call Today at 430 p.m. ET Dice#RNA Pharmaceuticals Inc. NASDAQD#RNA a leading developer of… bit.ly/2DclYaK #bioportfolio
MiNA Therapeutics Announces Publication of PreClinical Data Supporting Therapeutic Potential of Clinical Candidate MTLCEBPA in Liver Cancer and Liver Disease: Data Published in Oncogene Demonstrate Improvement of Liver Function and… bit.ly/2tz7TVi #bioportfolio
CRISPRCas9 System Applicable in Cultivated Strawberry: Gene function studies for the cultivated strawberry Fragaria ananassa are commonly conducted via gene silencing using intron hairpin #RNA ihp#RNAbased constructs. However this system is… bit.ly/2punWPK #bioportfolio
Benitec Biopharma Ltd BLT Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 15022018 Prices from USD $250: SummaryBenitec Biopharma Ltd Benitec is a research based clinical stage biotechnology company. The company… bit.ly/2FbymO0 #bioportfolio
Our podcasts uncover the truth behind vaccine development and highlight the trends in drug delivery devices that will definitely be of use to @BioPortfolio #BioPortfolio, #Vaccinations #HealthyRBKC, #YourVoiceIsAmplified
Bioportfolio.com is now DrugGenius.com! Follow the DG twitter account at bit.ly/2JIu40p #druggenius #bioportfolio
druggenius.com
Drug Genius | Prescription Medication Identification & Information
Detailed prescription drug and medication information reviewed by pharmaceutical professionals. Comprehensive articles that are written in a clear and concise manner. Specializing in Interactions,...
Great coverage from @BioPortfolio ! #Telehealth is changing and MediSprout is excited to lead the way. #BioPortfolio #tech #Amazon #AlexaSkills bioportfolio.com/news/article/3…
CRISPRCas9 System Applicable in Cultivated Strawberry: Gene function studies for the cultivated strawberry Fragaria ananassa are commonly conducted via gene silencing using intron hairpin #RNA ihp#RNAbased constructs. However this system is… bit.ly/2punWPK #bioportfolio
Alnylam Pharmaceuticals Inc ALNY Medical Equipment Deals and Alliances Profile Report Updated 13022018 Prices from USD $250: SummaryAlnylam Pharmaceuticals Inc Alnylam is a biopharmaceutical company which discovers develops and… bit.ly/2G7uc9t #bioportfolio
Genisphere LLC Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12032018 Prices from USD $250: SummaryGenisphere LLC Genisphere is a nanotechnology company which provides DNAbased targeted drug delivery solutions. The… bit.ly/2u4C3jt #bioportfolio
Qiagen NV QIA Medical Equipment Deals and Alliances Profile Report Updated 13022018 Prices from USD $250: SummaryQiagen NV Qiagen is a provider of molecular testing solutions. Its solutions include sample and assay technologies… bit.ly/2HEaVtn #bioportfolio
Highthroughput identification of #RNA nuclear enrichment sequences: In the postgenomic era thousands of putative noncoding regulatory regions have been identified such as enhancers promoters long noncoding #RNAs l#ncRNAs and a cadre of… bit.ly/2FGlyPS #bioportfolio
A single nucleotide incorporation step limits human telomerase repeat addition activity: Human telomerase synthesizes telomeric DNA repeats GGTTAGn onto chromosome ends using a short template from its integral telomerase #RNA hTR. However… bit.ly/2pfmS27 #bioportfolio
Mi#RNA Therapeutics Inc MIRN Financial and Strategic SWOT Analysis Review Report Updated 09032018 Prices from USD $300: SummaryMi#RNA Therapeutics Inc Mi#RNA is a clinical stage biopharmaceutical company that develops and commercializes… bit.ly/2FKePAj #bioportfolio
Alnylam Retains Global Rights to Lumasiran an Investigational ##RNAi Therapeutic for the Treatment of Primary Hyperoxaluria Type 1 PH1: Company Plans to Accelerate Development with Phase 3 Start in Late 2018 Lumasiran Granted Breakthrough… bit.ly/2FtLZZ2 #bioportfolio
Dice#RNA to Present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium: Dice#RNA Pharmaceuticals Inc. NasdaqD#RNA a leading developer of investigational ribonucleic acid interference ##RNAi therapeutics today… bit.ly/2tuFzDt #bioportfolio
MiNA Therapeutics Announces Publication of PreClinical Data Supporting Therapeutic Potential of Clinical Candidate MTLCEBPA in Liver Cancer and Liver Disease: Data Published in Oncogene Demonstrate Improvement of Liver Function and… bit.ly/2tz7TVi #bioportfolio
Dice#RNA Reports Fourth Quarter and Year End 2017 Financial and Operating Results and Provides Corporate Update: Management to Host Conference Call Today at 430 p.m. ET Dice#RNA Pharmaceuticals Inc. NASDAQD#RNA a leading developer of… bit.ly/2DclYaK #bioportfolio
A kinomewide ##RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8inhibitor treatment bit.ly/2D9wuQ2 #bioportfolio
Dice#RNA to Present at the Cowen and Company 38th Annual Health Care Conference: Dice#RNA Pharmaceuticals Inc. NasdaqD#RNA a leading developer of investigational ribonucleic acid interference ##RNAi therapeutics today announced that Douglas… bit.ly/2Ffhw0U #bioportfolio
Benitec Biopharma Ltd BLT Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 15022018 Prices from USD $250: SummaryBenitec Biopharma Ltd Benitec is a research based clinical stage biotechnology company. The company… bit.ly/2FbymO0 #bioportfolio
Celsion Corp CLSN Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 15022018 Prices from USD $250: SummaryCelsion Corp Celsion is an oncology company that focuses on developing a portfolio of new #cancer treatments… bit.ly/2F9sTXZ #bioportfolio
A single Nterminal phosphomimic disrupts TDP43 polymerization phase separation and #RNA splicing: TDP43 is an #RNAbinding protein active in splicing that concentrates into membraneless ribonucleoprotein granules and forms aggregates in… bit.ly/2CR1O60 #bioportfolio
Something went wrong.
Something went wrong.
United States Trends
- 1. #twitchrecap 10.9K posts
- 2. Fulham 39.2K posts
- 3. Slay 19.1K posts
- 4. #GivingTuesday 30.1K posts
- 5. #TADCFriend N/A
- 6. Lewandowski 22.9K posts
- 7. Larry 57K posts
- 8. Penn State 17.3K posts
- 9. Olmo 15.2K posts
- 10. Adam Thielen 2,843 posts
- 11. Trump Accounts 24.2K posts
- 12. Pedri 34.3K posts
- 13. #FULMCI 5,127 posts
- 14. Pat Kraft 1,577 posts
- 15. Foden 21.2K posts
- 16. Zion Williamson 1,011 posts
- 17. Cabinet 91.7K posts
- 18. #AppleMusicReplay 11.5K posts
- 19. Sleepy Don 4,334 posts
- 20. Susan Dell 10.7K posts